JOINN Laboratories (China) Co., Ltd. Class H (HK:6127) has released an update.
JOINN Laboratories (China) Co., Ltd. anticipates a decrease in both revenue and net profit for the first half of 2024, with expected revenue down by approximately 3.8% to 28.9% compared to the previous year. The company projects a net loss for shareholders, in contrast to the profit reported in the same period last year, highlighting challenges in its laboratory services and biological assets valuation.
For further insights into HK:6127 stock, check out TipRanks’ Stock Analysis page.
